Fuad El-Hibri

Insider Reports History

Entity
Individual
Location
2273 Research Blvd, Suite 400, Rockville, MD
Signature
/s/ Carl A. Valenstein, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fuad El-Hibri:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Emergent BioSolutions Inc. Director Common Stock 1.14M $2.07M $1.82 Dec 3, 2021 Direct
Emergent BioSolutions Inc. Director Common Stock 206K $376K $1.82 Dec 3, 2021 Indirect
Aptevo Therapeutics Inc. Director Common Stock 80.3K $73.1K $0.91 Dec 3, 2021 Direct
Aptevo Therapeutics Inc. Director Common Stock 7.37K $6.71K $0.91 Dec 3, 2021 Indirect
Aptevo Therapeutics Inc. Director Restricted Stock Unit 893 $813 $0.91 Jun 1, 2021 Direct
Aptevo Therapeutics Inc. Director Stock Option (right to buy) 2.68K Jun 1, 2021 Direct

Insider Reports Filed by Fuad El-Hibri

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EBS Emergent BioSolutions Inc. Dec 3, 2021 3 $0 4 Dec 7, 2021 Director
APVO Aptevo Therapeutics Inc. Dec 3, 2021 3 $0 4 Dec 7, 2021 Director
APVO Aptevo Therapeutics Inc. Jun 1, 2021 2 $0 4 Jun 2, 2021 Director